Back to Journals » Infection and Drug Resistance » Volume 12

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

Total article views   Abstract views HTML views PDF downloads Totals
1,128 Dovepress* 1,032 82+ 314 1,114
PubMed Central* 0 14 5 14
Totals 1,032 96 319 1,128
*Since 1 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar